StockData
XTL Biopharmaceuticals Ltd logo

XTL Biopharmaceuticals Ltd (XTLB) stock

XTLBNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 30, 2026Score 0/30
$1.62+0.08 (+5.19%)

Close on Nov 17, 2026Market cap $15.33MP/E –Yield –

XTL Biopharmaceuticals operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -$1.03M. The highest annual figure on record is -$707.00K in fiscal 2023.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$1.03M–
FY2024Dec 31, 2024-$1.62M–
FY2023Dec 31, 2023-$707.00K–
FY2022Dec 31, 2022-$901.00K–
FY2021Dec 31, 2021-$1.05M–
FY2020Dec 31, 2020-$850.00K–
FY2019Dec 31, 2019-$908.00K–
FY2018Dec 31, 2018-$816.00K–
FY2017Dec 31, 2017-$1.13M–
FY2016Dec 31, 2016-$1.73M–
FY2015Dec 31, 2015-$1.86M–

More XTL Biopharmaceuticals figures

See a number that looks wrong?